{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:32:03Z","timestamp":1772127123095,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuroblastoma is a childhood neurological tumor which affects hundreds of thousands of children worldwide, and information about its prognosis can be pivotal for patients, their families, and clinicians. One of the main goals in the related bioinformatics analyses is to provide stable genetic signatures able to include genes whose expression levels can be effective to predict the prognosis of the patients. In this study, we collected the prognostic signatures for neuroblastoma published in the biomedical literature, and noticed that the most frequent genes present among them were three:<jats:italic>AHCY<\/jats:italic>,<jats:italic>DPYLS3<\/jats:italic>, and<jats:italic>NME1<\/jats:italic>. We therefore investigated the prognostic power of these three genes by performing a survival analysis and a binary classification on multiple gene expression datasets of different groups of patients diagnosed with neuroblastoma. Finally, we discussed the main studies in the literature associating these three genes with neuroblastoma. Our results, in each of these three steps of validation, confirm the prognostic capability of<jats:italic>AHCY<\/jats:italic>,<jats:italic>DPYLS3<\/jats:italic>, and<jats:italic>NME1<\/jats:italic>, and highlight their key role in neuroblastoma prognosis. Our results can have an impact on neuroblastoma genetics research: biologists and medical researchers can pay more attention to the regulation and expression of these three genes in patients having neuroblastoma, and therefore can develop better cures and treatments which can save patients\u2019 lives.<\/jats:p>","DOI":"10.1186\/s13040-023-00325-1","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T09:02:44Z","timestamp":1677920564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastoma"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-7142","authenticated-orcid":false,"given":"Davide","family":"Chicco","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3288-0631","authenticated-orcid":false,"given":"Tiziana","family":"Sanavia","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2705-5728","authenticated-orcid":false,"given":"Giuseppe","family":"Jurman","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"key":"325_CR1","unstructured":"Cleveland Clinic. Neuroblastoma. https:\/\/my.clevelandclinic.org\/health\/diseases\/14390-neuroblastoma. Accessed 5 Aug 2022."},{"key":"325_CR2","unstructured":"American Cancer Society. What causes neuroblastoma? https:\/\/www.cancer.org\/cancer\/neuroblastoma\/causes-risks-prevention\/what-causes.html. Accessed 5 Aug 2022."},{"issue":"11","key":"325_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048877","volume":"7","author":"R Sanz-Pamplona","year":"2012","unstructured":"Sanz-Pamplona R, Berenguer A, Cordero D, Riccadonna S, Sol\u00e9 X, Crous-Bou M, et al. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review. PLoS ONE. 2012;7(11): e48877.","journal-title":"PLoS ONE."},{"issue":"1","key":"325_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms15081","volume":"8","author":"W Chung","year":"2017","unstructured":"Chung W, Eum HH, Lee HO, Lee KM, Lee HB, Kim KT, et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun. 2017;8(1):1\u201312.","journal-title":"Nat Commun."},{"issue":"3","key":"325_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gm325","volume":"4","author":"M Szyf","year":"2012","unstructured":"Szyf M. DNA methylation signatures for breast cancer classification and prognosis. Genome Med. 2012;4(3):1\u201312.","journal-title":"Genome Med."},{"issue":"4","key":"325_CR6","first-page":"1","volume":"13","author":"T Sanavia","year":"2012","unstructured":"Sanavia T, Aiolli F, Da San Martino G, Bisognin A, Di Camillo B. Improving biomarker list stability by integration of biological knowledge in the learning process. BMC Bioinformatics. 2012;13(4):1\u201311.","journal-title":"BMC Bioinformatics."},{"issue":"9","key":"325_CR7","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/cancers12092343","volume":"12","author":"D Cangelosi","year":"2020","unstructured":"Cangelosi D, Morini M, Zanardi N, Sementa AR, Muselli M, Conte M, et al. Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. Cancers. 2020;12(9):2343.","journal-title":"Cancers."},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fonc.2021.631546","volume":"11","author":"X Zhong","year":"2021","unstructured":"Zhong X, Tao Y, Chang J, Zhang Y, Zhang H, Wang L, et al. Prognostic Signature of Immune Genes and Immune-Related lncRNAs in Neuroblastoma: a Study Based on GEO and TARGET Datasets. Front Oncol. 2021;11:452.","journal-title":"Front Oncol."},{"issue":"1","key":"325_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/jcp.29842","volume":"236","author":"W Jin","year":"2021","unstructured":"Jin W, Zhang Y, Liu Z, Che Z, Gao M, Peng H. Exploration of the molecular characteristics of the tumor-immune interaction and the development of an individualized immune prognostic signature for neuroblastoma. J Cell Physiol. 2021;236(1):294\u2013308.","journal-title":"J Cell Physiol."},{"issue":"7","key":"325_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(09)70154-8","volume":"10","author":"J Vermeulen","year":"2009","unstructured":"Vermeulen J, Preter KD, Naranjo A, Vercruysse L, Roy NV, Hellemans J, et al. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN\/COG\/GPOH study. Lancet Oncol. 2009;10(7):663\u201371.","journal-title":"Lancet Oncol."},{"issue":"5","key":"325_CR11","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1158\/1078-0432.CCR-09-2607","volume":"16","author":"KD Preter","year":"2010","unstructured":"Preter KD, Vermeulen J, Brors B, Delattre O, Eggert A, Fischer M, et al. Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature. Clin Cancer Res. 2010;16(5):1532\u201341.","journal-title":"Clin Cancer Res."},{"issue":"47","key":"325_CR12","doi-asserted-by":"publisher","first-page":"19190","DOI":"10.1073\/pnas.1208215109","volume":"109","author":"LJ Valentijn","year":"2012","unstructured":"Valentijn LJ, Koster J, Haneveld F, Aissa RA, van Sluis P, Broekmans ME, et al. Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification. Proc Natl Acad Sci. 2012;109(47):19190\u20135.","journal-title":"Proc Natl Acad Sci."},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fgene.2018.00589","volume":"9","author":"X Zhong","year":"2018","unstructured":"Zhong X, Liu Y, Liu H, Zhang Y, Wang L, Zhang H. Identification of potential prognostic genes for neuroblastoma. Front Genet. 2018;9:589.","journal-title":"Front Genet."},{"issue":"7","key":"325_CR14","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1158\/1078-0432.CCR-11-2483","volume":"18","author":"I Garcia","year":"2012","unstructured":"Garcia I, Mayol G, R\u00edos J, Domenech G, Cheung NKV, Oberthuer A, et al. A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma. Clin Cancer Res. 2012;18(7):2012\u201323.","journal-title":"Clin Cancer Res."},{"issue":"5","key":"325_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.chembiol.2013.03.020","volume":"20","author":"SM Frumm","year":"2013","unstructured":"Frumm SM, Fan ZP, Ross KN, Duvall JR, Gupta S, VerPlank L, et al. Selective HDAC1\/HDAC2 Inhibitors Induce Neuroblastoma Differentiation. Chem Biol. 2013;20(5):713\u201325.","journal-title":"Chem Biol."},{"issue":"3","key":"325_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/CBM-191196","volume":"28","author":"Z Wang","year":"2020","unstructured":"Wang Z, Cheng H, Xu H, Yu X, Sui D. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma. Cancer Biomark. 2020;28(3):275\u201384.","journal-title":"Cancer Biomark."},{"issue":"D1","key":"325_CR17","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 2012;41(D1):D991\u20135.","journal-title":"Nucleic Acids Res."},{"key":"325_CR18","doi-asserted-by":"crossref","unstructured":"Parkinson H, Kapushesky M, Shojatalab M, Abeygunawardena N, Coulson R, Farne A, et\u00a0al. ArrayExpress\u2014a public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 2007;35(suppl_1):D747\u2013D750.","DOI":"10.1093\/nar\/gkl995"},{"issue":"W1","key":"325_CR19","doi-asserted-by":"publisher","first-page":"W83","DOI":"10.1093\/nar\/gkw199","volume":"44","author":"J Reimand","year":"2016","unstructured":"Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H, et al. g:Profiler\u2014a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 2016;44(W1):W83\u20139.","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"325_CR20","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/bioinformatics\/btab852","volume":"38","author":"A Alameer","year":"2022","unstructured":"Alameer A, Chicco D. geoCancerPrognosticDatasetsRetriever: a bioinformatics tool to easily identify cancer prognostic datasets on Gene Expression Omnibus (GEO). Bioinformatics. 2022;38(6):1761\u20133.","journal-title":"Bioinformatics."},{"issue":"14","key":"325_CR21","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and Bioconductor. Bioinformatics. 2007;23(14):1846\u20137.","journal-title":"Bioinformatics."},{"issue":"16","key":"325_CR22","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","volume":"21","author":"S Durinck","year":"2005","unstructured":"Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A, et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics. 2005;21(16):3439\u201340.","journal-title":"Bioinformatics."},{"issue":"1","key":"325_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-183","volume":"11","author":"M Ohtaki","year":"2010","unstructured":"Ohtaki M, Otani K, Hiyama K, Kamei N, Satoh K, Hiyama E. A robust method for estimating gene expression states using Affymetrix microarray probe level data. BMC Bioinformatics. 2010;11(1):1\u201314.","journal-title":"BMC Bioinformatics."},{"key":"325_CR24","doi-asserted-by":"crossref","unstructured":"Chicco D. geneExpressionFromGEO: an R package to facilitate data reading from Gene Expression Omnibus (GEO). In: Agapito G, editor. Microarray Data Analysis. vol. 2401 of Methods in Molecular Biology. New York City: Springer; 2021. p. 187\u2013194.","DOI":"10.1007\/978-1-0716-1839-4_12"},{"issue":"1","key":"325_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-474","volume":"12","author":"Q Li","year":"2011","unstructured":"Li Q, Birkbak NJ, Gy\u0151rffy B, Szallasi Z, Eklund AC. Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics. 2011;12(1):1\u20137.","journal-title":"BMC Bioinformatics."},{"issue":"2","key":"325_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017238","volume":"6","author":"C Chen","year":"2011","unstructured":"Chen C, Grennan K, Badner J, Zhang D, Gershon E, Jin L, et al. Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS ONE. 2011;6(2): e17238.","journal-title":"PLoS ONE."},{"issue":"7","key":"325_CR27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47\u2013e47.","journal-title":"Nucleic Acids Res."},{"key":"325_CR28","unstructured":"Koster J, Volckmann R, Zwijnenburg D, Molenaar P, Prins RW, Hoyng L, et\u00a0al. R2: genomics analysis and visualization platform. 2022. http:\/\/r2.amc.nl\/. Accessed 16 June 2022."},{"issue":"4","key":"325_CR29","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719\u201348.","journal-title":"J Natl Cancer Inst."},{"key":"325_CR30","first-page":"295","volume-title":"The handbook of research synthesis and meta-analysis","author":"SW Raudenbush","year":"2009","unstructured":"Raudenbush SW. Analyzing effect sizes: Random-effects models. In: Cooper H, Hedges LV, Valentine JC, editors. The handbook of research synthesis and meta-analysis. New York City: Russell Sage Foundation; 2009. p. 295\u2013315."},{"issue":"11","key":"325_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med."},{"issue":"4","key":"325_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics."},{"issue":"2","key":"325_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1536867X0400400204","volume":"4","author":"JA Sterne","year":"2004","unstructured":"Sterne JA, Harbord RM. Funnel Plots in Meta-analysis. Stata J. 2004;4(2):127\u201341.","journal-title":"Stata J."},{"key":"325_CR34","first-page":"97","volume-title":"New York City","author":"DG Kleinbaum","year":"2012","unstructured":"Kleinbaum DG, Klein M. The Cox proportional hazards model and its characteristics. In: Analysis Survival, editor. New York City. New York, USA: Springer; 2012. p. 97\u2013159."},{"issue":"1","key":"325_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random Forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn."},{"key":"325_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fdata.2022.979465","volume":"5","author":"D Chicco","year":"2022","unstructured":"Chicco D, Jurman G. The ABC recommendations for validation of supervised machine learning results in biomedical sciences. Front Big Data. 2022;5: 979465. https:\/\/doi.org\/10.3389\/fdata.2022.979465.","journal-title":"Front Big Data."},{"issue":"10","key":"325_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):1\u201316.","journal-title":"Genome Biol."},{"issue":"35","key":"325_CR38","first-page":"1","volume":"10","author":"Davide Chicco","year":"2017","unstructured":"Chicco D. Ten quick tips for machine learning in computational biology. BioData Min. 2017;10(35):1\u201317.","journal-title":"BioData Min."},{"issue":"2","key":"325_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","volume":"405","author":"BW Matthews","year":"1975","unstructured":"Matthews BW. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta Protein Struct. 1975;405(2):442\u201351.","journal-title":"Biochim Biophys Acta Protein Struct."},{"issue":"1","key":"325_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13040-021-00244-z","volume":"14","author":"D Chicco","year":"2021","unstructured":"Chicco D, T\u00f6tsch N, Jurman G. The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Min. 2021;14(1):1\u201322.","journal-title":"BioData Min."},{"key":"325_CR41","doi-asserted-by":"publisher","first-page":"47112","DOI":"10.1109\/ACCESS.2021.3068614","volume":"9","author":"D Chicco","year":"2021","unstructured":"Chicco D, Starovoitov V, Jurman G. The Benefits of the Matthews correlation coefficient (MCC) Over the Diagnostic Odds Ratio (DOR) in Binary Classification Assessment. IEEE Access. 2021;9:47112\u201324.","journal-title":"IEEE Access."},{"key":"325_CR42","doi-asserted-by":"publisher","first-page":"78368","DOI":"10.1109\/ACCESS.2021.3084050","volume":"9","author":"D Chicco","year":"2021","unstructured":"Chicco D, Warrens MJ, Jurman G. The Matthews correlation coefficient (MCC) is more informative than Cohen\u2019s Kappa and Brier score in binary classification assessment. IEEE Access. 2021;9:78368\u201381.","journal-title":"IEEE Access."},{"key":"325_CR43","unstructured":"Google. Google Scholar. 2022. http:\/\/scholar.google.com. Accessed 5 July 2022."},{"issue":"8","key":"325_CR44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/bioinformatics\/14.8.656","volume":"14","author":"M Rebhan","year":"1998","unstructured":"Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics. 1998;14(8):656\u201364.","journal-title":"Bioinformatics."},{"key":"325_CR45","doi-asserted-by":"crossref","unstructured":"Safran M, Dalah I, Alexander J, Rosen N, Iny\u00a0Stein T, Shmoish M, et\u00a0al. GeneCards version 3: the human gene integrator. Database. 2010;2010:1\u201316.","DOI":"10.1093\/database\/baq020"},{"issue":"1","key":"325_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinforma. 2016;54(1):1\u201330.","journal-title":"Curr Protoc Bioinforma."},{"key":"325_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.624079","volume":"10","author":"J Otte","year":"2021","unstructured":"Otte J, Dyberg C, Pepich A, Johnsen JI. MYCN function in neuroblastoma development. Front Oncol. 2021;10: 624079.","journal-title":"Front Oncol."},{"issue":"7391","key":"325_CR48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nature10910","volume":"483","author":"JJ Molenaar","year":"2012","unstructured":"Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature. 2012;483(7391):589\u201393.","journal-title":"Nature."},{"issue":"9","key":"325_CR49","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/nbt.3001","volume":"32","author":"C Wang","year":"2014","unstructured":"Wang C, Gong B, Bushel PR, Thierry-Mieg J, Thierry-Mieg D, Xu J, et al. The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat Biotechnol. 2014;32(9):926\u201332.","journal-title":"Nat Biotechnol."},{"key":"325_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00072","volume":"3","author":"A Roderwieser","year":"2019","unstructured":"Roderwieser A, Sand F, Walter E, Fischer J, Gecht J, Bartenhagen C, et al. Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma. JCO Precis Oncol. 2019;3:1\u201320.","journal-title":"JCO Precis Oncol."},{"issue":"3","key":"325_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng.2529","volume":"45","author":"TJ Pugh","year":"2013","unstructured":"Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, et al. The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013;45(3):279\u201384.","journal-title":"Nat Genet."},{"issue":"31","key":"325_CR52","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1200\/JCO.2006.06.1879","volume":"24","author":"A Oberthuer","year":"2006","unstructured":"Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol. 2006;24(31):5070\u20138.","journal-title":"J Clin Oncol."},{"issue":"5","key":"325_CR53","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1158\/2159-8290.CD-16-0861","volume":"8","author":"P Rajbhandari","year":"2018","unstructured":"Rajbhandari P, Lopez G, Capdevila C, Salvatori B, Yu J, Rodriguez-Barrueco R, et al. Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. Cancer Discov. 2018;8(5):582\u201399.","journal-title":"Cancer Discov."},{"issue":"1","key":"325_CR54","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41467-021-21247-8","volume":"12","author":"SA Hartlieb","year":"2021","unstructured":"Hartlieb SA, Sieverling L, Nadler-Holly M, Ziehm M, Toprak UH, Herrmann C, et al. Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome. Nat Commun. 2021;12(1):1269.","journal-title":"Nat Commun."},{"issue":"6","key":"325_CR55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00204-010-0602-0","volume":"85","author":"T Posser","year":"2011","unstructured":"Posser T, de Paula MT, Franco JL, Leal RB, da Rocha JBT. Diphenyl diselenide induces apoptotic cell death and modulates ERK1\/2 phosphorylation in human neuroblastoma SH-SY5Y cells. Arch Toxicol. 2011;85(6):645\u201351.","journal-title":"Arch Toxicol."},{"issue":"27","key":"325_CR56","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","volume":"33","author":"NR Pinto","year":"2015","unstructured":"Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, et al. Advances in Risk Classification and Treatment Strategies for Neuroblastoma. J Clin Oncol. 2015;33(27):3008\u201317.","journal-title":"J Clin Oncol."},{"issue":"4","key":"325_CR57","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1074\/jbc.M114.624056","volume":"290","author":"O Chayka","year":"2015","unstructured":"Chayka O, D\u2019Acunto CW, Middleton O, Arab M, Sala A. Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells. J Biol Chem. 2015;290(4):2198\u2013212.","journal-title":"J Biol Chem."},{"issue":"10\u201311","key":"325_CR58","first-page":"487","volume":"7","author":"MR Hamre","year":"1995","unstructured":"Hamre MR, Clark SH, Mirkin BL. Resistance to inhibitors of S-adenosyl-l-homocysteine hydrolase in C1300 murine neuroblastoma tumor cells is associated with increased methionine adenosyltransferase activity. Oncol Res Featuring Preclinical Clin Cancer Ther. 1995;7(10\u201311):487\u201392.","journal-title":"Oncol Res Featuring Preclinical Clin Cancer Ther."},{"issue":"10\u201311","key":"325_CR59","first-page":"433","volume":"5","author":"C Zhang","year":"1993","unstructured":"Zhang C, Bowlin T, Mirkin BL. Suppression of C-1300 murine neuroblastoma cell proliferation in tissue culture and tumor growth in vivo by (Z) 5\u2019-Fluoro-4\u2019,-5\u2019-didehydro-5\u2019-deoxyadenosine (MDL 28,842), an irreversible inhibitor of S-Adenosyl-L-homocysteine Hydrolase. Oncol Res Featuring Preclinical Clin Cancer Ther. 1993;5(10\u201311):433\u20139.","journal-title":"Oncol Res Featuring Preclinical Clin Cancer Ther."},{"issue":"14","key":"325_CR60","first-page":"3656","volume":"47","author":"RF O\u2019Dea","year":"1987","unstructured":"O\u2019Dea RF, Mirkin BL, Hogenkamp HP, Barten DM. Effect of adenosine analogues on protein carboxylmethyltransferase, S-adenosylhomocysteine hydrolase, and ribonucleotide reductase activity in murine neuroblastoma cells. Cancer Res. 1987;47(14):3656\u201361.","journal-title":"Cancer Res."},{"issue":"4","key":"325_CR61","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0197-0186(87)90068-4","volume":"10","author":"V Ramakrishnan","year":"1987","unstructured":"Ramakrishnan V, Borchardt RT. Adenosine dialdehyde and neplanocin A: potent inhibitors of S-adenosylhomocysteine hydrolase in neuroblastoma N2a cells. Neurochem Int. 1987;10(4):423\u201331. https:\/\/doi.org\/10.1016\/0197-0186(87)90068-4.","journal-title":"Neurochem Int."},{"issue":"8","key":"325_CR62","first-page":"1852","volume":"59","author":"RS Dwivedi","year":"1999","unstructured":"Dwivedi RS, Wang LJ, Mirkin BL. S-adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: a novel mechanism of drug resistance. Cancer Res. 1999;59(8):1852\u20136.","journal-title":"Cancer Res."},{"key":"325_CR63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mehy.2016.10.008","volume":"97","author":"EM Novak","year":"2016","unstructured":"Novak EM, Halley NS, Gimenez TM, Rangel-Santos A, Azambuja AMP, Brumatti M, et al. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma. Med Hypotheses. 2016;97:22\u20135.","journal-title":"Med Hypotheses."},{"key":"325_CR64","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.isci.2019.10.020","volume":"21","author":"G Oliynyk","year":"2019","unstructured":"Oliynyk G, Ruiz-P\u00e9rez MV, Sainero-Alcolado L, Dzieran J, Zirath H, Gallart-Ayala H, et al. MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma. Iscience. 2019;21:188\u2013204.","journal-title":"Iscience."},{"issue":"7","key":"325_CR65","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.7150\/jca.69408","volume":"13","author":"K Tan","year":"2022","unstructured":"Tan K, Wu W, Zhu K, Lu L, Lv Z. Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5. J Cancer. 2022;13(7):2105\u201325.","journal-title":"J Cancer."},{"issue":"1","key":"325_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-014-0066-9","volume":"33","author":"M Kanda","year":"2014","unstructured":"Kanda M, Nomoto S, Oya H, Shimizu D, Takami H, Hibino S, et al. Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer. J Exp Clin Cancer Res. 2014;33(1):1\u20138.","journal-title":"J Exp Clin Cancer Res."},{"issue":"12","key":"325_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079654","volume":"8","author":"T Kawahara","year":"2013","unstructured":"Kawahara T, Hotta N, Ozawa Y, Kato S, Kano K, Yokoyama Y, et al. Quantitative proteomic profiling identifies DPYSL3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complex. PLoS ONE. 2013;8(12): e79654. https:\/\/doi.org\/10.1371\/journal.pone.0079654.","journal-title":"PLoS ONE."},{"issue":"2","key":"325_CR68","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.yexcr.2005.08.005","volume":"310","author":"V Rosslenbroich","year":"2005","unstructured":"Rosslenbroich V, Dai L, Baader SL, Noegel AA, Gieselmann V, Kappler J. Collapsin response mediator protein-4 regulates F-actin bundling. Exp Cell Res. 2005;310(2):434\u201344. https:\/\/doi.org\/10.1016\/j.yexcr.2005.08.005.","journal-title":"Exp Cell Res."},{"key":"325_CR69","doi-asserted-by":"publisher","unstructured":"Alabed YZ, Pool M, Tone SO, Sutherland C, Fournier AE. GSK3\u03b2\u00a0regulates myelin-dependent axon outgrowth inhibition through CRMP4. J Neurosci. 2010;30(16):5635\u201343. https:\/\/doi.org\/10.1523\/JNEUROSCI.6154-09.2010.","DOI":"10.1523\/JNEUROSCI.6154-09.2010"},{"issue":"12","key":"325_CR70","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1158\/1535-7163.MCT-07-0133","volume":"6","author":"Z Li","year":"2007","unstructured":"Li Z, Tan F, Thiele CJ. Inactivation of glycogen synthase kinase-3 contributes to brain-derived neutrophic factor\/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Mol Cancer Ther. 2007;6(12):3113\u201321.","journal-title":"Mol Cancer Ther."},{"issue":"12","key":"325_CR71","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/cas.12278","volume":"104","author":"F Tan","year":"2013","unstructured":"Tan F, Wahdan-Alaswad R, Yan S, Thiele CJ, Li Z. Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma. Cancer Sci. 2013;104(12):1586\u201392. https:\/\/doi.org\/10.1111\/cas.12278.","journal-title":"Cancer Sci."},{"issue":"9","key":"325_CR72","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.3390\/ijms21093319","volume":"21","author":"K Adam","year":"2020","unstructured":"Adam K, Lesperance J, Hunter T, Zage PE. The potential functional roles of NME1 histidine kinase activity in neuroblastoma pathogenesis. Int J Mol Sci. 2020;21(9):3319. https:\/\/doi.org\/10.3390\/ijms21093319.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"325_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep01351","volume":"3","author":"M Carotenuto","year":"2013","unstructured":"Carotenuto M, Pedone E, Diana D, de Antonellis P, D\u017eeroski S, Marino N, et al. Neuroblastoma tumorigenesis is regulated through the Nm23-H1\/h-Prune C-terminal interaction. Sci Rep. 2013;3(1):1\u201311. https:\/\/doi.org\/10.1038\/srep01351.","journal-title":"Sci Rep."},{"issue":"9","key":"325_CR74","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/sj.cdd.4400720","volume":"7","author":"A Negroni","year":"2000","unstructured":"Negroni A, Venturelli D, Tanno B, Amendola R, Ransac S, Cesi V, et al. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Cell Death Differ. 2000;7(9):843\u201350. https:\/\/doi.org\/10.1038\/sj.cdd.4400720.","journal-title":"Cell Death Differ."},{"issue":"10","key":"325_CR75","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1349-7006.2005.00091.x","volume":"96","author":"J Okabe-Kado","year":"2005","unstructured":"Okabe-Kado J, Kasukabe T, Honma Y, Hanada R, Nakagawara A, Kaneko Y. Clinical significance of serum NM23-H1 protein in neuroblastoma. Cancer Sci. 2005;96(10):653\u201360. https:\/\/doi.org\/10.1111\/j.1349-7006.2005.00091.x.","journal-title":"Cancer Sci."}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-023-00325-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-023-00325-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-023-00325-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T08:01:50Z","timestamp":1702022510000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-023-00325-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/s13040-023-00325-1","relation":{},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"19 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authorizations for the usage of patients\u2019 data have been obtained by the original curators of the studies which released the datasets publicly.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}